BioPortfolio Biotechnology Pharmaceutical Healthcare Medical Life Science Drug Discovery Disease

BioNews
Biotechnology, Pharmaceutical and Life Science News
search help

Search Results

Documents 1-15 out of 15 found
  Current Search:  cleviprex: 15     

HTML
100%
Nationwide recall of clevidipine butyrate (Cleviprex'The Medicines Company) expanded: Certain lots may con
Recall -- Firm Press Release FDA posts press releases and other notices of recalls and market withdrawals from the firms involved as a service to consumers, the media, and other interested parties.

FDA does not endorse either the product or the company.

FOR...

Pharmacist.com:  Mar 19 2010 9:50PM
Matching: cleviprex
Find similar documents
HTML
100%
The Medicines Company expands nationwide recall for certain lots of Cleviprex
The Medicines Company announced that it is voluntarily expanding the recall of Cleviprex (clevidipine butyrate) injectable emulsion due to the potential presence of visible particulate matter which has been observed in some vials.

Four (4) additional...

PharmaBiz:  Mar 19 2010 2:08PM
Matching: cleviprex
Find similar documents
HTML
100%
The Medicines Company Provides Update on PTO Litigation
Companies mentioned in this article: The Medicines Company PARSIPPANY, NJ -- (Marketwire) -- 03/19/10 -- The Medicines Company (NASDAQ: MDCO) today provided an update on actions by the U.S.

Patent and Trademark Office (the "PTO") related to the Company's...

Freshnews.com:  Mar 19 2010 11:00PM
Matching: cleviprex
Find similar documents
HTML
100%
Expanded Cleviprex Recall
The Medicines Company has expanded a voluntary recall of Cleviprex (clevidipine butyrate) injectable emulsion to include 4 additional lots (68-407-DJ, Exp.

08/2010; 68-408-DJ, Exp.

08/2011; 71-101-DJ and 71-106-DJ, Exp.

11/2011).

The previously...

Facts & Comparisons:  Mar 18 2010 7:58PM
Matching: cleviprex
Find similar documents
HTML
100%
The Medicines Company Announces Decision in PTO and FDA Litigation
PARSIPPANY, NJ -- (Marketwire) -- 03/16/10 -- The Medicines Company (NASDAQ: MDCO) today announced that the U.S.

District Court for the Eastern District of Virginia issued an order in the Company's lawsuit against the U.S.

Patent and Trademark Office (the ...

Sys-Con Belgium:  Mar 17 2010 8:17PM
Matching: cleviprex
Find similar documents
HTML
100%
The Medicines Company Announces Decision in PTO and FDA Litigation
The Medicines Company (NASDAQ: MDCO) today announced that the U.S.

District Court for the Eastern District of Virginia issued an order in the Company's lawsuit against the U.S.

Patent and Trademark Office (the "PTO"), the U.S.

Food and Drug Administration...

NewsBlaze:  Mar 17 2010 4:23AM
Matching: cleviprex
Find similar documents
HTML
100%
The Medicines Company Announces Decision in PTO and FDA Litigation
Companies mentioned in this article: The Medicines Company PARSIPPANY, NJ -- (Marketwire) -- 03/16/10 -- The Medicines Company (NASDAQ: MDCO) today announced that the U.S.

District Court for the Eastern District of Virginia issued an order in the Company's...

Freshnews.com:  Mar 17 2010 1:42AM
Matching: cleviprex
Find similar documents
HTML
100%
The Medicines Company Announces Decision in PTO and FDA Litigation
PARSIPPANY, NJ--(Marketwire - 03/16/10) - The Medicines Company (NASDAQ:MDCO - News) today announced that the U.S.

District Court for the Eastern District of Virginia issued an order in the Company's lawsuit against the U.S.

Patent and Trademark Office (the...

Yahoo! Canada:  Mar 17 2010 1:41AM
Matching: cleviprex
Find similar documents
HTML
100%
The Medicines Company Announces Decision in PTO and FDA Litigation
The Court set aside the PTO's denial of the Company's patent term extension application and sent the matter back to the PTO for reconsideration.

The Court further ordered that the PTO take the actions necessary to ensure that '404 patent does not expire...

Stockwatch:  Mar 17 2010 1:03AM
Matching: cleviprex
Find similar documents
HTML
100%
The Medicines Company Announces Decision in PTO and FDA Litigation
Refer to a friend Marketwire 2010 PARSIPPANY, NJ -- (Marketwire) -- 03/16/10 -- The Medicines Company (NASDAQ: MDCO) today announced that the U.S.

District Court for the Eastern District of Virginia issued an order in the Company's lawsuit against the U.S.

PR inside:  Mar 17 2010 12:52AM
Matching: cleviprex
Find similar documents
HTML
100%
The Medicines Company Announces Decision in PTO and FDA Litigation
PARSIPPANY, NJ -- 03/16/10 -- The Medicines Company (NASDAQ: MDCO) today announced that the U.S.

District Court for the Eastern District of Virginia issued an order in the Company's lawsuit against the U.S.

Patent and Trademark Office (the "PTO"), the U.S....

Earthtimes.org:  Mar 17 2010 12:45AM
Matching: cleviprex
Find similar documents
HTML
100%
The Medicines Company Announces Decision in PTO and FDA Litigation
PARSIPPANY, NJ -- (Marketwire) -- 03/16/10 -- The Medicines Company (NASDAQ: MDCO) today announced that the U.S.

District Court for the Eastern District of Virginia issued an order in the Company's lawsuit against the U.S.

Patent and Trademark Office (the ...

EuroInvestor.co.uk:  Mar 17 2010 12:22AM
Matching: cleviprex
Find similar documents
HTML
100%
The Medicines Company Announces Decision in PTO and FDA Litigation
PARSIPPANY, NJ -- (MARKET WIRE) -- 03/16/10 -- The Medicines Company (NASDAQ: MDCO) today announced that the U.S.

District Court for the Eastern District of Virginia issued an order in the Company's lawsuit against the U.S.

Patent and Trademark Office (the ...

Street Insider:  Mar 17 2010 12:22AM
Matching: cleviprex
Find similar documents
HTML
100%
Medicines Co. 4Q loss widens on charges
Medicines Co.

loss widens in 4Q due to tax reserve charge, milestone payments, other costs Buzz up!

Companies: Related Quotes {'s' : 'mdco','k' : 'c10,l10,p20,t10','o' : '','j' : ''} PARSIPPANY, N.J!

(AP) -- Drugmaker The Medicines Co.

on Wednesday said...

Cafepharma:  Feb 18 2010 9:24AM
Matching: cleviprex
Find similar documents
HTML
100%
Medicines Co. 4Q loss widens on charges
Drugmaker The Medicines Co.

on Wednesday said its loss widened in the fourth quarter due to a series of one-time costs, including a tax reserve charge and acquisition expenses.

The company said it lost $73.5 million, or $1.40 per share, during the quarter....

Bioscience Technology Online:  Feb 17 2010 8:57PM
Matching: cleviprex
Find similar documents


 

Nothing in this website should be used in place of personal medical advice from your own qualified medical practitioner.

All rights reserved. All other trademarks recognized.
Copyright 1997-2009 - BioPortfolio Limited.